Mark Cuban Cost Plus Drug Company
pharmaceutical manufacturing
Based in TX
AI Overview
With $111K in lobbying spend across 9 quarterly filings, Mark Cuban Cost Plus Drug Company is an active lobbying client. Their lobbying covers 1 issue area. Active from 2020 to 2022.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $21K |
| 2021 | $60K |
| 2022 | $30K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Mark Cuban Cost Plus Drug Company disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
domestic drug manufacturing
domestic drug manufacturing and drug price transparency provisions within HR 3
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.